The immunological basis of the hygiene hypothesis

Chemical Immunology and Allergy

Volumn 91, Issue , 2006, Pages 30-48

  Renz, Harald ^a   Blümer, Nicole ^a   Virna, Simona ^a   Sel, Serdar ^a   Garn, Holger ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN;

ALLERGIC DISEASE; CELLULAR IMMUNITY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; HEREDITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INNATE IMMUNITY; LIFESTYLE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

EID: 30744443018     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000090228     Document Type: Review

References (72)

1. Strachan DP: Hay fever, hygiene, and household size. Br Med J 1989;299:1259-1260.
2. Strachan DP: Allergy and family size: A riddle worth solving. Clin Exp Allergy 1997;27:235-236.
3. Hesselmar B, Aberg N, Aberg B, Eriksson B, Bjorksten B: Does early exposure to cat or dog protect against later allergy development? Clin Exp Allergy 1999;29:611-617.
4. Alm JS, Swartz J, Lilja G, Scheynius A, Pershagen G: Atopy in children of families with an anthroposophic lifestyle. Lancet 1999;353:1485-1488.
5. Celedon JC, Wright RJ, Litonjua AA, et al: Day care attendance in early life, maternal history of asthma, and asthma at the age of 6 years. Am J Respir Crit Care Med 2003;167:1239-1243.
6. Nowak D, Heinrich J, Jorres R, et al: Prevalence of respiratory symptoms, bronchial hyperresponsiveness and atopy among adults: West and East Germany. Eur Respir J 1996;9:2541-2552.
7. Heinrich J, Hoelscher B, Frye C, Meyer I, Wjst M, Wichmann HE: Trends in prevalence of atopic diseases and allergic sensitization in children in Eastern Germany. Eur Respir J 2002;19:1040-1046.
8. Webber MP, Carpiniello KE, Oruwariye T, Appel DK: Prevalence of asthma and asthma-like symptoms in inner-city elementary schoolchildren. Pediatr Pulmonol 2002;34:105-111.
9. Braun-Fahrlander C, Gassner M, Grize L, et al: Prevalence of hay fever and allergic sensitization in farmer's children and their peers living in the same rural community. SCARPOL team. Swiss Study on Childhood Allergy and Respiratory Symptoms with Respect to Air Pollution. Clin Exp Allergy 1999;29:28-34.
10. Von Ehrenstein OS, Von Mutius E, Illi S, Baumann L, Bohm O, von Kries R: Reduced risk of hay fever and asthma among children of farmers. Clin Exp Allergy 2000;30:187-193.
11. Kilpelainen M, Terho EO, Helenius H, Koskenvuo M: Farm environment in childhood prevents the development of allergies. Clin Exp Allergy 2000;30:201-208.
12. Braun-Fahrlander C, Riedler J, Herz U, et al: Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002;347:869-877.
13. Gehring U, Bolte G, Borte M, et al: Exposure to endotoxin decreases the risk of atopic eczema in infancy: A cohort study. J Allergy Clin Immunol 2001;108:847-854.
14. Gereda JE, Leung DY, Thatayatikom A, et al: Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet 2000;355:1680-1683.
15. van Strien RT, Engel R, Holst O, et al: Microbial exposure of rural school children, as assessed by levels of N-acetyl-muramic acid in mattress dust, and its association with respiratory health. J Allergy Clin Immunol 2004;113:860-867.
16. Lauener RP, Birchler T, Adamski J, et al: Expression of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children. Lancet 2002;360:465-466.
17. Roy SR, Schiltz AM, Marotta A, Shen Y, Liu AH: Bacterial DNA in house and farm barn dust. J Allergy Clin Immunol 2003;112:571-578.
18. Yang IA, Barton SJ, Rorke S, et al: Toll-like receptor 4 polymorphism and severity of atopy in asthmatics. Genes Immun 2004;5:41-45.
19. Eder W, Von Mutius E: Hygiene hypothesis and endotoxin: What is the evidence? Curr Opin Allergy Clin Immunol 2004;4:113-117.
20. Ahmad-Nejad P, Mrabet-Dahbi S, Breuer K, et al: The toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J Allergy Clin Immunol 2004;113:565-567.
21. Aaby P, Shaheen SO, Heyes CB, et al: Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin Exp Allergy 2000;30:644-650.
22. Von Mutius E, Pearce N, Beasley R, et al: International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax 2000;55:449-453.
23. Alm JS, Lilja G, Pershagen G, Scheynius A: BCG vaccination does not seem to prevent atopy in children with atopic heredity. Allergy 1998;53:537.
24. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M: Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001;108:516-520.
25. Van de WJ, Keen CL, Gershwin ME: The influence of chronic yogurt consumption on immunity. J Nutr 1999;129:S1492-S1495.
26. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E: Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003;361:1869-1871.
27. Duren-Schmidt K, Pichler J, Ebner C, et al: Prenatal contact with inhalant allergens. Pediatr Res 1997;41:128-131.
28. Szepfalusi Z, Loibichler C, Pichler J, Reisenberger K, Ebner C, Urbanek R: Direct evidence for transplacental allergen transfer. Pediatr Res 2000;48:404-407.
29. Kihlstrom A, Lilja G, Pershagen G, Hedlin G: Exposure to high doses of birch pollen during pregnancy, and risk of sensitization and atopic disease in the child. Allergy 2003;58:871-877.
30. Lewert RM, Mandlowitz S: Schistosomiasis: Prenatal induction of tolerance to antigens. Nature 1969;224:1029-1030.
31. Herz U, Ahrens B, Scheffold A, Joachim R, Radbruch A, Renz H: Impact of in utero Th2 immunity on T cell deviation and subsequent immediate-type hypersensitivity in the neonate. Eur J Immunol 2000;30:714-718.
32. Uthoff H, Spenner A, Reckelkamm W, et al: Critical role of preconceptional immunization for protective and nonpathological specific immunity in murine neonates. J Immunol 2003;171:3485-3492.
33. Victor JR Jr, Fusaro AE, Duarte AJ, Sato MN: Preconception maternal immunization to dust mite inhibits the type I hypersensitivity response of offspring. J Allergy Clin Immunol 2003;111:269-277.
34. Tukenmez F, Bahceciler NN, Barlan IB, Basaran MM: Effect of pre-immunization by killed Mycobacterium bovis and vaccae on immunoglobulin E response in ovalbumin-sensitized newborn mice. Pediatr Allergy Immunol 1999;10:107-111.
35. Ozdemir C, Akkoc T, Bahceciler NN, Kucukercan D, Barlan IB, Basaran MM: Impact of Mycobacterium vaccae immunization on lung histopathology in a murine model of chronic asthma. Clin Exp Allergy 2003;33:266-270.
36. Hopfenspirger MT, Agrawal DK: Airway hyperresponsiveness, late allergic response, and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice. J Immunol 2002;168:2516-2522.
37. Li XM, Srivastava K, Huleatt JW, Bottomly K, Burks AW, Sampson HA: Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model. J Immunol 2003;170:3289-3295.
38. Braga EG, Ananias RZ, Mussalem JS, et al: Treatment with Propionibacterium acnes modulates the late phase reaction of immediate hypersensitivity in mice. Immunol Lett 2003;88:163-169.
39. Kim YS, Kwon KS, Kim DK, Choi IW, Lee HK: Inhibition of murine allergic airway disease by Bordetella pertussis. Immunology 2004;112:624-630.
40. Han X, Fan Y, Wang S, et al: Dendritic cells from Chlamydia-infected mice show altered Toll-like receptor expression and play a crucial role in inhibition of allergic responses to ovalbumin. Eur J Immunol 2004;34:981-989.
41. Fujiwara D, Inoue S, Wakabayashi H, Fujii T: The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both Th1/Th2 cytokine expression and balance. Int Arch Allergy Immunol 2004;135:205-215.
42. Repa A, Grangette C, Daniel C, et al: Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy. Vaccine 2003;22:87-95.
43. Bashir ME, Louie S, Shi HN, Nagler-Anderson C: Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy. J Immunol 2004;172:6978-6987.
44. Gerhold K, Blumchen K, Bock A, et al: Endotoxins prevent murine IgE production, T(H)2 immune responses, and development of airway eosinophilia but not airway hyperreactivity. J Allergy Clin Immunol 2002;110:110-116.
45. Delayre-Orthez C, de Blay F, Frossard N, Pons F: Dose-dependent effects of endotoxins on allergen sensitization and challenge in the mouse. Clin Exp Allergy 2004;34:1789-1795.
46. Gerhold K, Bluemchen K, Franke A, Stock P, Hamelmann E: Exposure to endotoxin and allergen in early life and its effect on allergen sensitization in mice. J Allergy Clin Immunol 2003;112:389-396.
47. Blümer N, Herz U, Wegmann M, Renz H: Prenatal lipopolysaccharide- exposure prevents allergic sensitization and airway inflammation, but not airway responsiveness in a murine model of experimental asthma. Clin Exp Allergy 2005;35:397-402.
48. Banerjee B, Kelly KJ, Fink JN, Henderson JD Jr, Bansal NK, Kurup VP: Modulation of airway inflammation by immunostimulatory CpG oligodeoxynucleotides in a murine model of allergic aspergillosis. Infect Immun 2004;72:6087-6094.
49. Sayers I, Severn W, Scanga CB, Hudson J, Le Gros G, Harper JL: Suppression of allergic airway disease using mycobacterial lipoglycans. J Allergy Clin Immunol 2004;114:302-309.
50. Weigt H, Muhlradt PF, Larbig M, Krug N, Braun A: The Toll-like receptor-2/6 agonist macrophage-activating lipopeptide-2 cooperates with IFN-gamma to reverse the Th2 skew in an in vitro allergy model. J Immunol 2004;172:6080-6086.
51. Busse WW, Rosenwasser LJ: Mechanisms of asthma. J Allergy Clin Immunol 2003;111:S799-S804.
52. Farrar JD, Asnagli H, Murphy KM: T helper subset development: Roles of instruction, selection, and transcription. J Clin Invest 2002;109:431-435.
53. O'Garra A, Arai N: The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol 2000;10:542-550.
54. Umetsu DT, McIntire JJ, Akbari O, Macaubas C, Dekruyff RH: Asthma: An epidemic of dysregulated immunity. Nat Immunol 2002;3:715-720.
55. Medzhitov R: Toll-like receptors and innate immunity. Nat Rev Immunol 2001;1:135-145.
56. Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 2003;21:335-376.
57. Sabroe I, Read RC, Whyte MK, Dockrell DH, Vogel SN, Dower SK: Toll-like receptors in health and disease: Complex questions remain. J Immunol 2003;171:1630-1635.
58. Rodriguez D, Keller AC, Faquim-Mauro EL, et al: Bacterial lipopolysaccharide signaling through Toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2 activity. J Immunol 2003;171:1001-1008.
59. Kitagaki K, Jain VV, Businga TR, Hussain I, Kline JN: Immunomodulatory effects of CpG oligodeoxynucleotides on established Th2 responses. Clin Diagn Lab Immunol 2002;9:1260-1269.
60. Fageras BM, Hmani-Aifa M, Lindstrom A, et al: A TLR4 polymorphism is associated with asthma and reduced lipopolysaccharide-induced interleukin-12(p70) responses in Swedish children. J Allergy Clin Immunol 2004;114:561-567.
61. Boguniewicz M, Martin RJ, Martin D, et al: The effects of nebulized recombinant interferon-gamma in asthmatic airways. J Allergy Clin Immunol 1995;95:133-135.
62. Barnes PJ: Cytokine modulators as novel therapies for asthma. Annu Rev Pharmacol Toxicol 2002;42:81-98.
63. Bach JF: The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002;347:911-920.
64. Holm TL, Nielsen J, Claesson MH: CD4+CD25+ regulatory T cells. I. Phenotype and physiology. APMIS 2004;112:629-641.
65. Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003;4:330-336.
66. O'Garra A, Vieira P: Regulatory T cells and mechanisms of immune system control. Nat Med 2004;10:801-805.
67. Ling EM, Smith T, Nguyen XD, et al: Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004;363:608-615.
68. Moseman EA, Liang X, Dawson AJ, et al: Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J Immunol 2004;173:4433-4442.
69. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J: Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003; 197:403-411.
70. Riedler J, Braun-Fahrlander C, Eder W, Schrauer M, Waser M, Maisch S, Carr D, Schierl R, Nowak D, Von Mutius E: ALEX Study Team: Exposure to farming in early life and development of asthma and allergy: A cross-sectional survey. Lancet 2001;358:1129-1133.
71. Böttcher MF, Bjorksten B, Gustafson S, Voor T, Jenmalm MC: Endotoxin levels in Estonian and Swedish house dust and atopy in infancy. Clin Exp Allergy 2003;33:295-300.
72. Koppelman GH, Jansen DF, Schouten JP, van der Heide S, Bleecker ER, Meyers DA, Postma DS: Sibling effect on atopy in children of patients with asthma. Clin Exp Allergy 2003;33:170-175.